Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06360562 · ClinicalTrials.gov registry record · NA

Reconnecting to Ourselves and Others in Virtual Meetings (ROOM)

A NA study of Anxiety Disorders and Mood Disorders, sponsored by Massachusetts General Hospital.

Active
Registry status
NA
Development phase
174
Enrollment target
1
Study location

NCT06360562 is a NA study of Anxiety Disorders and Mood Disorders that is active but no longer recruiting, run by Massachusetts General Hospital. The registered enrollment target is 174 participants, below the 1,138-participant average among 84 other Anxiety Disorders trials with a reported enrollment target (85% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06360562, a NA study of Anxiety Disorders and Mood Disorders, is active but no longer recruiting, sponsored by Massachusetts General Hospital.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
174 participants
Enrollment target
1
Study location

Study Summary

This study aimed to determine the feasibility and acceptability of delivering Resilience Training in multi-user virtual reality.

Interventions

  • BEHAVIORAL Resilience Training

Study Locations (1)

Massachusetts

  • Massachusetts General Hospital - Charlestown

Trial Details

FieldValue
Enrollment Target 174 participants
Start Date 2020-09-15
Est. Completion 2025-12-31
Phase NA

Sponsor

Massachusetts General Hospital

2,032 total trials

What the Registry Record Tells You About NCT06360562

The ClinicalTrials.gov registry entry for NCT06360562 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 174 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,138-participant average among 84 other Anxiety Disorders trials with a reported enrollment target (85% lower). The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Anxiety Disorders appearing as the primary indexed condition, and to 1 intervention - of which Resilience Training is the first listed.

NCT06360562 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT06360562 about?

NCT06360562 is a clinical study titled "Reconnecting to Ourselves and Others in Virtual Meetings (ROOM)". This study aimed to determine the feasibility and acceptability of delivering Resilience Training in multi-user virtual reality.

What is the current status of trial NCT06360562?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 174 participants. The study started on 2020-09-15. Estimated completion is 2025-12-31.

What conditions does trial NCT06360562 study?

This clinical trial studies the following conditions: Anxiety Disorders, Mood Disorders, Psychotic Disorders.

What interventions are being tested in trial NCT06360562?

The interventions under investigation include: Resilience Training (BEHAVIORAL).

Who is sponsoring clinical trial NCT06360562?

This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06360562 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Anxiety Disorders

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.